* Nutex Health Inc NUTX.OQ reported a quarterly adjusted
loss of
1 cent per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for a loss of
one cent per share.
* Revenue was $56.33 million; analysts expected $56.05
million.
* Nutex Health Inc's reported EPS for the quarter was a loss
of 1
cent.
* In the last 30 days, two analysts negatively revised
earnings
estimates
* Nutex Health Inc shares had fallen by 50.0% this
quarter and
lost 73.4% so far this year.
* The company reported a quarterly loss of $5.15 million.
* Wall Street's median 12-month price target for Nutex
Health Inc
is $3.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data May
15 at 11:51 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 -0.01 -0.01 Met
Dec. 31 2022 -0.01 -0.02 Missed